Cabazitaxel for the therapy of metastatic castration‐resistant prostate cancer in the aftermath of the CHAARTED trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1464-410x|116|6|839-840

ISSN: 1464-4096

Source: BJU INTERNATIONAL, Vol.116, Iss.6, 2015-12, pp. : 839-840

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract